Verona Pharma plc (VRNA)

Verona Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	438.02	399.76	271.77	227.83	148.38	187.99
Cash & Short-Term Investments	438.02	399.76	271.77	227.83	148.38	187.99
Cash Growth	8.26%	47.09%	19.29%	53.54%	-21.07%	360.66%
Accounts Receivable	82.86	31.5	-	-	-	-
Other Receivables	4.06	5.76	10.95	9.28	15.58	8.26
Receivables	86.92	37.26	10.95	9.28	15.58	8.26
Inventory	8.61	6.25	-	-	-	-
Prepaid Expenses	11.43	7.57	3.62	2.5	4.04	4.54
Other Current Assets	3.87	2.74	3.37	3.39	2.06	1.72
Total Current Assets	548.85	453.57	289.71	243	170.06	202.5
Property, Plant & Equipment	2.57	3.15	2.87	0.93	0.98	1.16
Long-Term Investments	15	15	15	15	15	-
Goodwill	0.55	0.55	0.55	0.55	0.55	0.55
Other Long-Term Assets	5.91	1.97	-	-	-	-
Total Assets	572.87	474.24	308.12	259.47	186.59	204.21
Accounts Payable	3.43	11.27	3.49	2.91	10.04	0.18
Accrued Expenses	46.42	17.86	3.59	13.75	22.26	10.86
Current Portion of Long-Term Debt	-	0.69	-	-	-	-
Current Portion of Leases	1.01	1.12	1.18	0.68	0.65	0.8
Current Income Taxes Payable	-	8.89	-	0.28	0.15	-
Other Current Liabilities	0.37	2.86	0.44	1.41	0.33	2.36
Total Current Liabilities	51.24	42.68	8.69	19.03	33.42	14.2
Long-Term Debt	242.43	225.76	48.37	9.77	4.87	4.64
Long-Term Leases	0.93	1.24	1.78	0.21	0.29	0.51
Total Liabilities	294.6	269.68	58.84	29	38.58	19.35
Common Stock	45.02	45.02	42.77	40.53	31.86	31.79
Additional Paid-In Capital	805.92	728.2	601.06	529.19	385.07	366.41
Retained Earnings	-567.1	-562.4	-388.43	-333.1	-263.72	-207.05
Treasury Stock	-0.96	-1.66	-1.52	-1.55	-0.6	-1.7
Comprehensive Income & Other	-4.6	-4.6	-4.6	-4.6	-4.6	-4.6
Shareholders' Equity	278.27	204.56	249.28	230.47	148.01	184.85
Total Liabilities & Equity	572.87	474.24	308.12	259.47	186.59	204.21
Total Debt	244.37	228.81	51.33	10.65	5.81	5.95
Net Cash (Debt)	193.64	170.95	220.44	217.18	142.57	182.04
Net Cash Growth	-31.43%	-22.45%	1.50%	52.33%	-21.68%	360.33%
Net Cash Per Share	2.31	2.10	2.78	3.28	2.41	5.54
Filing Date Shares Outstanding	86.19	84.98	86.83	78.99	60.37	57.93
Total Common Shares Outstanding	85.99	84.63	80.44	75.79	60.01	57.91
Working Capital	497.61	410.89	281.02	223.97	136.64	188.3
Book Value Per Share	3.24	2.42	3.10	3.04	2.47	3.19
Tangible Book Value	277.73	204.01	248.74	229.92	147.46	184.31
Tangible Book Value Per Share	3.23	2.41	3.09	3.03	2.46	3.18

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q